Qurient spun out from Institut Pasteur Korea, a research institute focused on curing infectious diseases, in 2008.
Qurient Therapeutics, a Novartis Venture Fund-backed biotech, has listed on Korea’s Kosdaq stock exchange.
Qurient raised KrW32.5bn ($26m) in its IPO through the sale of 1.5 million shares at KrW21,000 each.
Qurient spun out from Institut Pasteur Korea, a research institute focused on curing infectious diseases, in 2008.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
